June 9 - ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe - Strategic Partnership Leverages ICON’s Extensive European Capabilities

Welcome to ICON

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies

In a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis.

We have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution.

These services are delivered by the following ICON Divisions.

ICON Central Laboratories - Global central laboratory services dedicated exclusively to clinical trials




ICON Clinical Research - Planning , management, execution and analysis of Phase IIb – IV clinical trials



ICON Contracting Solutions - Contract and permanent staffing solutions for pharmaceutical and biotech companies



ICON Development Solutions - Product development planning , early phase clinical development, and expertise in regulatory affairs, pk/ biopharmaceutics and bioanalytics



ICON Medical Imaging - Medical imaging based development solutions, including independent imaging review and database delivery to regulatory authorities





Q1 2009 results
by clicking on the button below:( Call on April 28th, 2009 14:00GMT)


To listen to this call please click here.
>




ICON Central Laboratories in Singapore Moves to Ne..
New Safety Regulations Drive Greater Need for Reso..
ICON Announces Collaboration to Develop New Transl..
ICON Selected to Manage Lilly Clinical Trial Site ..
ICON Named A Favourite Contract Research Organisat..
ICON Acquires Assets of Qualia Clinical Services, ..
ICON reports 9% increase in revenue, 25% increase ..
ICON Announces Appointment of Dr. Anthony J. Murph..
ICON Completes CAP Accreditation of its Central La..
 
the current time is :
 

ICON Japan
Japanese Version

 
  Disclaimer | Privacy Policy
North America Latin America Africa Europe Asia Australia